250+ investors that invest in your industry and stage
Get 250+ investors tailored to your startup
  • Invest in your industry and stage
  • Emails & contact info included
  • Excel and CSV export
  • Automatically
Trusted by 3,000+ startups

Top 50 Medical Device Startup Investors in Oceania in May 2025

A list of 50 angel investors and VC (Venture Capital) funds that invest in Medical device startups based in Oceania. We rank investors based on the number of investments they made in Medical device companies from Oceania. We update this investor list every month.

Top 50 Medical Device Startup Investors in Oceania in May 2025

Investor Medical Device Oceania investments
Brandon Capital 7
Artesian VC 6
Medical Research Commercialisation Fund (MRCF) 6
Pacific Channel 4
Icehouse Ventures 4
Melbourne Angels 4
Cure Kids Ventures 3
New Zealand Growth Capital Partners 3
Global from Day One 3
Sydney Angels 3
IP Group 3
Breakthrough Victoria 3
Uniseed 3
Uniservices 3
Uniseed Ventures 2
Flying Kiwis 2
Flying Kiwi Angels 2
Punakaiki Fund 2
Brisbane Angels 2
Regal Funds Management 2
Global Health Investment Fund (GHIF) 2
Allan Moss 2
GD1 2
Matū Group 2
K1W1 2
Ramsay Health Care 1
Grand Challenges Canada 1
Topcon Healthcare 1
OneVentures 1
HealthCare Ventures 1
Development Bank of Wales 1
UniSA Ventures 1
Fund WA 1
Movac 1
Powerhouse Ventures 1
Tuhua Fund 1
Bridgewest Group 1
Quayside Holdings 1
New Zealand Venture Investment Fund 1
South Australian Venture Capital Fund 1
Skip Capital 1
National Vision 1
Booster 1
CoAct Capital 1
Hostplus 1
Upswell Ventures 1
LCO Capital 1
Andrew R Banks 1
Auckland UniServices 1
Significant Early Venture Capital 1
Find investors that fund startups like yours. Automatically.
Our algorithm will find investors that invest in your industry, stage, and geography.
Investor list
Brandon Capital VC Fund · Melbourne, Victoria, Australia · 3 investments in the past 12 months
Brandon Capital invests in the most promising biomedical opportunities that have the potential to improve the lives of patients.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • CatalYm — Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.
  • AdvanCell — AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
  • Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
Artesian VC VC Fund · Melbourne, Victoria, Australia · 6 investments in the past 12 months
Artesian Capital Management is an alternative investments management company, which was spun out of ANZ Banking Group's capital markets business in 2004, with backing from ANZ Private Equity. Artesian's founding partners, purchased ANZ's stake in 2005. The company has subsequently been fully owned by partners and staff. Since 2004,Artesian has managed specialised funds focused on credit arbitrage and relative-value strategies across global financial markets. In 2008, while continuing to manage credit relative value investment strategies from its New York, London and Singapore offices, Artesian began to make principal investments in seed/early-stage ventures from its offices in Sydney, Melbourne and Shanghai. In 2011, Artesian launched the first of its early stage venture capital funds and now manages AUD +255m. Artesian's VC strategy is to partner with best of breed accelerators, incubators, angel groups and university programs. In 2017, Artesian launched its China VC Fund with a USD 50m cornerstone investment industry super fund Hostplus. Artesian will soon launch a Southeast Asia VC Fund.
Show more
Investment focus
  • Software, Artificial Intelligence, Information Technology
  • Seed, Series A, Pre-Seed
  • Australia, United States, Hong Kong
Portfolio highlights
  • Strong Room AI — Software that enables high-strength care through streamlined workflows, continuous analytics, surfaced insights and safeguarded data.
  • Modern Synthesis — Combining biology, material science, engineering and human ingenuity, we create textiles that are circular by nature, and customisable by design.
  • Fleet Space Technologies — Fleet is an agile, next generation connectivity company. Our mission is to Connect Everything using cutting-edge communications and space technologies to maximise the resource efficiency of human civilisation and enable the next industrial revolution with our free, ubiquitous connectivity platform.
Medical Research Commercialisation Fund (MRCF) VC Fund · Melbourne, Victoria, Australia
Medical Research Commercialisation Fund (MRCF) provides dedicated, investment funding to support the commercialisation of early-stage medical research discoveries that originate from its member institutes. The collaborative nature of the MRCF seeks to foster best practice in the commercialisation of medical innovations.
Show more
Investment focus
  • Biotechnology, Health Care, Medical
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Glyscend Therapeutics — Glyscend develops a revolutionary approach to treating type 2 diabetes. The company began with the insight that bariatric surgery can lead to the immediate remission of the disease, and has since been engaged in the development of a non-invasive approach which will act on the same mechanism as surgery but fit within the current care pathway. Thecompany's technology is an orally ingestible intestinal coating that prevents the stimulation of duodenal mucosa and inhibits key neurohormonal pathways in the proximal gut. Glyscend is devoted to providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. Meanwhile, the company aims to provide endocrinologists and primary care physicians with the innovative tools they need to treat the disease instead of merely managing it. It was founded in 2014 by co-founders Ashish Nimgaonkar, Michael Parlato, and Pratik Patel.
  • Currus Biologics — Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
  • Azura Ophthalmics — Azura Ophthalmics is a clinical-stage company that develops an innovative portfolio of compounds to advance treatments for MGD, the leading cause of DED. By targeting the root cause of MGD, Azura brings the promise of improved health and well-being to millions of people worldwide who suffer from MGD and other ocular surface diseases where treatmentoptions are currently lacking. Azura is underpinned by an experienced management team with an established track record of successfully developing and commercializing novel treatments for ocular surface diseases. The company headquartered in Tel Aviv-Yafo, Israel with operations in Australia and the U.S.
Pacific Channel VC Fund · Auckland, Auckland, New Zealand · 3 investments in the past 12 months
Investing in great people solving hard problems to create a better future.
Show more
Investment focus
  • Medical Device, Medical, Information Technology
  • Seed, Series A
  • New Zealand, Australia
Portfolio highlights
  • PHNXX — PHNXX provides containerised clean and reliable energy solutions for business operations.
  • Conry Tech — Conry Tech is a climate tech company, reinventing air-conditioning to decarbonise and improve comfort, founded by renowned HVAC industry revolutionising experts.
  • Green Gravity — Green Gravity is an electric power generation company that enables renewable energy transition using energy storage technology.
Icehouse Ventures VC Fund · Auckland, Auckland, New Zealand · 12 investments in the past 12 months
Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • New Zealand, United States, United Kingdom
Portfolio highlights
  • Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
  • Watchful — Watchful operates as an AI security company.
  • Crimson Education — Crimson Education is the world's leading higher educational consultancy helping students around the world gain admission into leading US and UK universities by up to 400%!
Melbourne Angels VC Fund · Melbourne, Victoria, Australia
Melbourne Angels was formed in Melbourne, Australia in early 2007. Melbourne Angels is the leading group of private investors in Victoria who actively invest in early stage and growth technology companies.The group has a strong and experienced core of members that generate deal flow, are experienced in evaluation of business propositions and actas mentors for the other members and the entrepreneurs. The members vary in age, gender, ethnicity, profession and type of experience. All members have experience of success at being entrepreneurial.This award winning group is consistently one of the most active startup investors in the country.
Show more
Investment focus
  • Biotechnology, Information Technology, Manufacturing
  • Angel, Seed, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Aurtra — Aurtra delivers highly cost-effective asset management solutions for power distribution transformers through online condition monitoring and state of the art analysis.They provide the insight to significantly reduce capital costs through maximum asset utilisation. Aurtra is an Australian company, based in sunny Brisbane, Australia. Aurtra wasincorporated in 2016 and has built its IP upon a foundation of world’s best practice technology from The University of Queensland, following a decade of transformer research between academia and industry. Aurtra’s three founders, all with success commercialising hardware and software technology, recognised the potential of the technology and its beneficial impact for asset management in the power distribution industry.
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Seitec — Seitec is a security company that manufactures seismic security applications and instruments for civilian and military markets.
Cure Kids Ventures VC Fund · Auckland, Auckland, New Zealand
Investing in innovation for a healthy childhood Investing in innovation for a healthy childhood About Cure Kids Ventures Cure Kids Ventures is a seed and early stage investment fund that invests in the commercialisation of innovations in products and services with a potential to
Show more
Investment focus
  • Medical Device, SaaS, Medical
  • Seed, Pre-Seed, Series A
  • New Zealand
Portfolio highlights
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
New Zealand Growth Capital Partners VC Fund · 2 investments in the past 12 months
The New Zealand Growth Capital Partners (formerly New Zealand Venture Investment Fund) was established to support early-stage technology companies and to stimulate private investment into this space.
Show more
Investment focus
  • Software, SaaS, Information Technology
  • Seed, Series A, Funding Round
  • New Zealand, United States
Portfolio highlights
  • Scannable — Safety Equipment Management System
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Marama Labs — Marama Labs provides an integrated chemical analysis platform that empowers customers to optimize their production processes and match their products and brands to customer needs, with ease.
Global from Day One VC Fund · Auckland, Auckland, New Zealand
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more
Investment focus
  • Software, SaaS, Medical Device
  • Seed, Series A, Funding Round
  • New Zealand, United States, China
Portfolio highlights
  • eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
  • Flowingly — Unlock Team Productivity. Streamline Approvals. Increase Compliance. Easy To Use, No-Code Process Mapping & Workflow Automation Platform.
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Sydney Angels VC Fund · Sydney, New South Wales, Australia
Sydney Angels is a not-for-profit angel investment membership organisation. Since our establishment in 2008, they have stayed true to our mission of supporting the early-stage ecosystem by running processes and events that connect our investing members with promising early-stage companiesThey believe that encouraging smart investment in startupcompanies will benefit both our members’ portfolios and Australia’s emergent innovation economy.They see this as the ultimate win-win situation. Sydney Angels is led by an elected committee of ten volunteers who meet weekly. It is supported by an operations manager and alliance partners.
Show more
Investment focus
  • Software, Health Care, SaaS
  • Seed, Angel, Series A
  • Australia, United States
Portfolio highlights
  • Okkular — Okkular is an AI based fashion tech startup.
  • Apollo Secure — Cyber for Humans - an automated cybersecurity platform for startups and small businesses to improve security maturity and simplify security compliance.
  • Mary Technology — Generate detailed chronologies from documents in minutes with Mary Technology. Achieve 90%+ time reduction and ensure 99%+ accuracy. Try for free.
IP Group VC Fund · London, England, United Kingdom · 6 investments in the past 12 months
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more
Investment focus
  • Health Care, Biotechnology, Information Technology
  • Seed, Series A, Funding Round
  • United Kingdom, United States, Australia
Portfolio highlights
  • Lumai — Lumai delivers fully optical computing for a quicker, smarter and more sustainable world. Lumai power the revolution of fully optical computing by working at the nexus of photonics and machine learning.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Diffblue — Diffblue Cover uses next generation autonomous AI to automate unit testing so that Java development teams can build better applications faster
Breakthrough Victoria VC Fund · Melbourne, Victoria, Australia · 10 investments in the past 12 months
The Breakthrough Victoria Fund is a $2 billion investment by the Victorian Government to drive investment in research and innovation.
Show more
Investment focus
  • Manufacturing, Health Care, Software
  • Funding Round, Series A, Seed
  • Australia, United States, Philippines
Portfolio highlights
  • EntroMat — EntroMat is a pioneering deep-tech startup transforming the metal powder industry through the advancement of high entropy material (HEM) powders.
  • Umps Health — Umps offers a 24/7 personal alarm that helps you live independently with peace of mind. Easy to use, always connected.
  • Quantum Brilliance — Quantum Brilliance builds room temperature quantum computers powered by synthetic diamond, enabling applications in everyday computing, including edge and massively parrellelized computing.
Uniseed VC Fund · Brisbane, Queensland, Australia · 3 investments in the past 12 months
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Series B
  • Australia, United States, United Kingdom
Portfolio highlights
  • Diraq — Diraq uses spins in silicon quantum dots as qubits. Diraq's qubits are compatible with existing CMOS processes and can fit billions of qubits on a single chip. To transform our world, quantum computers need billions of qubits and Diraq has the IP, the team and the plan to get there.
  • Celosia Therapeutics — The Celosia Therapeutics approach is the result of advances in gene therapies and a better understanding of the molecular pathways that contribute to neurodegenerative diseases.
  • Kinoxis Therapeutics — Developing novel therapeutics for social dysfunction and substance use disorders.
Uniservices VC Fund
Auckland University's commercialisation arm
Show more
Investment focus
  • Medical Device, SaaS, Audio
  • Seed, Pre-Seed
  • New Zealand
Portfolio highlights
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Uniseed Ventures VC Fund · Brisbane, Queensland, Australia
Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.
Show more
Investment focus
  • Biotechnology, Manufacturing, Health Care
  • Series A, Seed, Funding Round
  • Australia, United States, United Kingdom
Portfolio highlights
  • BioScout — Welcome to BioScout, your partner in revolutionizing the agriculture industry with cutting-edge automated disease detection technology for crop growers and viticulture.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Morse Micro — Morse Micro is a fast-growing wireless integrated circuit solutions company that is reinventing Wi-Fi for the Internet of Things (IoT). The company was founded by Wi-Fi pioneers and innovators, Michael De Nil and Andrew Terry, joined by the original Wi-Fi inventor Prof. Neil Weste and wireless industry veterans, whose teams designed Wi-Fi chipsinto billions of smartphones. Headquartered in Australia with offices in China and the U.S., Morse Micro’s strong and diverse system team, portfolio of IP and patents, enables Wi-Fi HaLow connectivity across the complete IoT ecosystem, from surveillance systems and access control to industrial automation and mobile devices, allowing connected devices to reach farther. www.morsemicro.com
Flying Kiwis VC Fund
Super-seeded by new entry: Flying Kiwi Angels
Show more
Investment focus
  • SaaS, 3D Technology, Medical Device
  • Seed
  • New Zealand
Portfolio highlights
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
Flying Kiwi Angels VC Fund · Auckland, Auckland, New Zealand
Flying Kiwi Angels ? Helping Kiwi Startups
Show more
Investment focus
  • Software, Information Technology, Apps
  • Seed, Angel, Pre-Seed
  • New Zealand
Portfolio highlights
  • FileInvite — The simplest, most secure, document collection platform for professionals. Request files, forms, data and e-signatures all through a secure client portal.
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Kara Technologies — Content accessibility using a signing avatar. Accessible solutions are at the core of all that we do here at Kara. One of our main goals is finding smarter ways of using technology that will help build a better future for everyone, in all areas of life.
Punakaiki Fund VC Fund · Auckland, Auckland, New Zealand
Punakaiki Fund Limited makes long-term investments into high-growth, revenue-generating New Zealand companies. The company holds 20 investments, $32.3 million in assets, and is raising money in December 2017 for further investment.
Show more
Investment focus
  • Software, SaaS, Mobile Apps
  • Seed, Series A, Series B
  • New Zealand, United States
Portfolio highlights
  • Formus — Formus Labs develops software technologies for orthopedic planning and analysis. Our mission is to improve outcomes and efficiencies through seamless and highly scalable integration of AI and computational modelling in the orthopedic clinical workflow. Based in Auckland, New Zealand, Formus Labs draws on over 10 years of research andcommercialisation experience, with operations in New Zealand, Australia, and soon in the USA.
  • Whip Around — Whip Around develops and builds solutions that tackle the paper-based compliance burden for a wide variety of transport companies in the United States and around the world. Effortlessly manage your fleet inspections, compliance, preventative maintenance, work orders, reporting & more! Create powerful checklists for your assets. Have yourdrivers conduct inspections anywhere, anytime via the Whip Around mobile app. Get alerts sent to you immediately, view the reports from the management dashboard and manage faults with ease. Come see why more than 85,000 users globally love Whip Around. Trial Whip Around free for 7 days!
  • projectworks — Project Works is a cloud based workforce management platform designed to help professional & creative services businesses better manage their organisations in the areas of project management, project financials, and people management. Our mission is to provide a platform that enables world class services businesses to get the most out of theirexisting workforce, and enable them to grow.
Brisbane Angels VC Fund · Brisbane, Queensland, Australia · 3 investments in the past 12 months
Formed in late 2006, the Brisbane Angels Pty Ltd is a large group of private investors who actively invest in early stage technology companies, usually in South East Queensland, Australia. The members are typically active or semi-retired former senior business executives, who apart from financial input can provide much needed value adding toinvestee companies through hands-on management experience and high level business networks.
Show more
Investment focus
  • Information Technology, Software, Artificial Intelligence
  • Seed, Angel, Funding Round
  • Australia, United States, New Zealand
Portfolio highlights
  • Tendl — Write tenders faster with Tendl's AI tool. Keep your data private and secure. Easy installation, no sharing. Boost productivity and streamline your contract opportunities.
  • ReciMe — The #1 app to save recipes from Instagram, TikTok, YouTube, Facebook & more!
  • Shopfront — Shopfront provides tools for automated list generation, publishing, managing, and delisting of products across various marketplaces.
Regal Funds Management VC Fund · Sydney, New South Wales, Australia
Regal Funds Management was founded in 2004 by Andrew and Philip King. Regal utilises a long/short investment strategy and performs investment management and investment advisory services to a number of Australian Unit Trusts and Cayman Island Companies.
Show more
Investment focus
  • Software, Financial Services, FinTech
  • Funding Round, Series B, Convertible Note
  • Australia, United States, United Kingdom
Portfolio highlights
  • Nykaa — Nykaa is an e-Commerce platform for different beauty and wellness products for men and women. They also offer comprehensive content including product reviews, beauty how-to videos, articles by experts, and an e-beauty magazine. Their helpline helps to choose products and services best suited for customer's needs. Nykaa's products areauthentic sourced directly from brands and provide a delivery experience.Nykaa was founded in 2012 by Falguni Nayar and is headquartered in Mumbai, Maharashtra, India.
  • Send Payments — SendFX provides cross-border payment and remittance services to individuals and SMEs.
  • Send Payments — Send is a fast-growing fintech delivering embedded finance solutions to well-known brands.
Global Health Investment Fund (GHIF) VC Fund · New York, New York, United States
The Global Health Investment Fund (GHIF) is a $108 million social impact investment fund designed to provide financing to advance the development of drugs, vaccines, diagnostics and other interventions against diseases that disproportionately burden low- and middle-income countries. GHIF supports late-stage innovations for public health challengessuch as malaria, pre-eclampsia, cholera, HIV and river blindness, with an emphasis on infectious diseases and maternal/infant health issues that cause significant morbidity and mortality in resource-limited settings. GHIF may also make investments that improve or expand access to existing products—such as developing pediatric formulations of approved therapeutics or improving the stability of widely-used global health vaccines.As an investment fund with a limited time-horizon, GHIF seeks opportunities that have a high probability of successful commercialization within two or three years. Products with “dual market” potential are of greatest interest; i.e., those that will have a clear impact on public health in developing countries but also have value in high-income countries. High-volume / low-margin products, such as essential vaccines, are also of significant interest.GHIF employs a range of investment structures including mezzanine debt, convertible debt, preferred equity and project financing with an average investment target of approximately $10 million per project. Each GHIF project must advance the Fund’s social impact objectives and demonstrate the ability to achieve commercial success.
Show more
Investment focus
  • Health Care, Biotechnology, Medical Device
  • Series B, Series C, Funding Round
  • United States, India, Austria
Portfolio highlights
  • Monod Bio — Monod Bio l Simple. Powerful. Biosensors for Medicine & Biotech.
  • CXL Ophthalmics — CXLO is developing a minimally invasive treatment for an ectatic corneal disease that can bring early intervention to millions of patients globally.
  • Endpoint Health — Endpoint Health is a precision-first therapeutics company. By rewriting the molecule-first drug development model, we aim to deliver precision therapies that have the potential to improve outcomes for patients with immune-driven illnesses.
Allan Moss Angel · Sydney, New South Wales, Australia
Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Funding Round, Series A, Seed
  • Australia, United States, The Netherlands
Portfolio highlights
  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
GD1 VC Fund · Auckland, Auckland, New Zealand · 5 investments in the past 12 months
GD1 is a Venture Capital firm that invests with high conviction in exciting technology companies originating from New Zealand. Our team is passionate about creating and growing global businesses, and our goal is to transform NZ made into the next generation of globally disruptive tech solutions.
Show more
Investment focus
  • Software, Information Technology, SaaS
  • Seed, Series A, Pre-Seed
  • New Zealand, United States, China
Portfolio highlights
  • EarnOS — EarnOS is the fully remote company that provides Global Ad & Payments Platform powered by Web3.
  • Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
  • Ivo — Ivo reduces the time, effort, and cost of negotiating agreements.
Matū Group VC Fund · Auckland, Auckland, New Zealand
Investing in scalable science and deep tech start-ups in Aotearoa NZ. We operate venture capital funds that invest in science and deep tech through a hands-on, active approach.
Show more
Investment focus
  • Biotechnology, Robotics, Nanotechnology
  • Seed
  • New Zealand, United States
Portfolio highlights
  • Ligar — Providing molecular filtration solutions to companies in the food, beverage, health, therapeutics, flavour and aroma industries. Our unique MIP and Polymer technology enables companies to improve their products and operational processes by extracting, reducing or concentrating flavours or compounds.
  • Alimetry — Alimetry is a health technology startup based in Auckland, New Zealand, developing breakthrough solutions for diagnosing disorders of gastrointestinal (GI) function.
  • PowerON — Dielectric Elastomers for Soft Robotics
K1W1 VC Fund · Auckland, Auckland, New Zealand · 4 investments in the past 12 months
K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.
Show more
Investment focus
  • Software, Artificial Intelligence, Biotechnology
  • Seed, Series A, Funding Round
  • New Zealand, United States
Portfolio highlights
  • Auror — The platform for retailers focused on improving safety, productivity, and profitability. Auror is used by leading Loss Prevention teams in thousands of stores.
  • Emerge — Emerge is a financial management tool for businesses. It is a digital-only banking option designed to help Kiwi businesses operate more quickly, economically, and efficiently.
  • Zenno Astronautics — Zenno Astronautics hardware and software products ensure satellite missions are effectively managed, guaranteeing maximum economic returns and responsible use of space.
Ramsay Health Care VC Fund · Sydney, New South Wales, Australia
Ramsay Health Care provides health care services to public and private patients. Its health care services comprise day surgery procedures and complex surgeries, as well as psychiatric care and rehabilitation services. It operates approximately 235 hospitals and day surgery facilities with approximately 25,000 beds in Australia, the United Kingdom,France, Indonesia, Malaysia, Maldives, and Italy. Paul Ramsay founded Ramsay Health Care in 1964. It has its headquarters in Sydney in Australia.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Series A
  • Australia
Portfolio highlights
  • Harrison.ai — Harrison.ai is a clinician-led healthcare AI company using deep learning to improve the odds of IVF success for thousands of patients. The company leverages deep learning to solve the biggest challenges in healthcare and seeks to improve patient outcomes. It empowers physicians and healthcare providers with customized AI-enabled tools thatintegrate into existing clinical workflows which ultimately lead to improved patient outcomes.Harrison.ai uses the deskside DGX Station for experimentation, research, and development. The company uniquely combines exceptional deep learning expertise with clinical experience to develop and deploy healthcare AI solutions. Harrison.ai’s IVY deep learning model analyzes the full five-day video feed from an embryo scope, helping it surpass the performance of AI tools that provide insights based on still images.Harrison.ai's mission is to continuously innovate and commercialize more efficient and more affordable healthcare products and services to healthcare providers and patients.Harrison.ai was founded in 2018 and is headquartered in Barongarook, Victoria, Australia.
Grand Challenges Canada VC Fund · Toronto, Ontario, Canada
Learn how we find, fund and support high-impact innovations
Show more
Investment focus
  • Health Care, Medical Device, Biotechnology
  • Grant, Seed, Debt Financing
  • Canada, United States, Australia
Portfolio highlights
  • OmniVis — OmniVis is a technology company creating handheld devices to rapidly detect dangerous pathogens - saving food and saving lives.
  • Hewatele — Hewatele is a social enterprise that provides affordable quality medical oxygen to all needy patients together with its affiliates CPHD and Mediquip Global.
  • Nivi — Nivi is the best digital health chatbot built for whatsapp and rooted in behavioral science. Nivi enables users to take charge of their own health and works with private and public agencies to driver better public health outcomes.
Topcon Healthcare VC Fund · Oakland, New Jersey, United States · 2 investments in the past 12 months
Topcon Healthcare empowers providers with advanced imaging, diagnostic solutions and intelligent data technology, offering a more fully integrated approach to diagnosis and treatment in eyecare.
Show more
Investment focus
  • Health Care, Medical Device, Health Diagnostics
  • Series A
  • New Zealand
Portfolio highlights
  • RetiSpec — RetiSpec is a medical imaging company using advanced AI for the detection of neurodegenerative diseases through hyperspectral imaging of the eye.
  • Toku Eyes — Instant Healthcare Diagnostics. Toku Eyes developed a multi-modal artificial intelligence platform for instant healthcare diagnostics...
  • Retinai — RetinAI optimises and simplifies clinics, research and pharmaceutical workflows to improve healthcare. To achieve this goal, the company builds tools to collect, analyze and organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning. RetinAI has proprietarytechnology that provides unforeseen image quality enhancement, as well as automatic analysis of medical data for hospitals, private practitioners, pharmaceutical companies and device manufacturers at similar level of performance as a human would produce.
OneVentures VC Fund · Sydney, New South Wales, Australia · 6 investments in the past 12 months
OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.
Show more
Investment focus
  • Software, Health Care, Information Technology
  • Series A, Debt Financing, Funding Round
  • Australia, United States, Israel
Portfolio highlights
  • Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
  • BiVACOR — BiVACOR is a privately held company founded in 2008. Their staff includes world-class engineers, medical specialists, and business executives, who are diligently working to advance this ground-breaking technology. Together, they have established a strong collaborative network that extends both nationally and internationally. Their worldheadquarters is located in Houston, Texas, USA, and their international office is in Brisbane, Australia.
  • ImmVirX — ImmVirX is an Australian company founded in 2019 with a mission to improve outcomes for patients with cancer types in which immunotherapy treatments have limited effect.
HealthCare Ventures VC Fund · Cambridge, Massachusetts, United States
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
Show more
Investment focus
  • Biotechnology, Health Care, Pharmaceutical
  • Series B, Series A, Series C
  • United States, Australia, United Kingdom
Portfolio highlights
  • Colorescience — Know Better Skin with Colorescience. From mineral sunscreen to clinical skincare products, achieve a clear, even complexion and protect your skin from the damaging effects of the sun and environmental aggressors such as pollution. Shop Now!
  • Leap Therapeutics — Leap Therapeutics, Inc., a clinical-stage biopharmaceutical company, is engaged in acquiring and developing novel therapeutics. The company focus is to identify translational-stage molecules in the areas of cell signaling and immuno-oncology.
  • Proteostasis Therapeutics — Proteostasis Therapeutics is discovering and developing novel small molecule therapeutics designed to control the body's protein homeostasis, or Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases. These novel therapies, or Proteostasis Regulators, aredesigned to treat multiple genetic and degenerative disorders associated with deficiencies of the Proteostasis Network, such as emphysema, type II diabetes, Alzheimer's Disease and Huntington's Disease.
Development Bank of Wales VC Fund · Cardiff, Cardiff, United Kingdom · 20 investments in the past 12 months
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed, Funding Round, Debt Financing
  • United Kingdom, Australia, United States
Portfolio highlights
  • Driverly — Driverly is an Insurtech based in Cardiff, Wales, with a mission to bring insurance to the 21st century. We offer AI-powered Insurance Intelligence at different stages of the customer life cycle.
  • nisien.ai — Industry-leading artificial and human intelligence for effective and ethical online safeguarding with Nisien AI.
  • Lumin Solutions
UniSA Ventures VC Fund
UniSA Ventures is the technology commercialisation and investment management company of the University of South Australia (UniSA).
Show more
Investment focus
  • Software, Health Care, Biotechnology
  • Seed
  • Australia
Portfolio highlights
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Framework — Framework is an all-in-one tool for teams and individuals. You can use Framework to do anything from project management, sales pipeline & customer relationship management, wiki & documentation, team communication (team chat, voice & video calls), and meeting scheduling.Framework can help organize your ideas with nodes. A node is apiece of information and each node is connected and related to other nodes.
Fund WA VC Fund · Perth, Western Australia, Australia
FundWA is a Western Australian venture capital fund that invests in technology-enabled innovative businesses in Western Australia.
Show more
Investment focus
  • Medical, Health Care, Medical Device
  • Seed, Series A
  • Australia
Portfolio highlights
  • Hola Health — 24 hour online doctors & GP consults via telehealth appointments in 15 minutes. Get instant scripts online, medical certificate online anywhere in Australia.
  • VitalTrace — VitalTrace is a medical device company helps mothers and children during labour and delivery by innovating new monitoring devices.
Movac VC Fund · Wellington, Wellington, New Zealand · 2 investments in the past 12 months
Movac is New Zealand's most experienced technology investor and is deeply integrated into the Kiwi tech sector. We've been actively investing since 1998.
Show more
Investment focus
  • Software, E-Commerce, Enterprise Software
  • Seed, Series A, Funding Round
  • New Zealand, United States, Australia
Portfolio highlights
  • Kry10 — Kry10 is a safe operating system for SDMs.It makes the transition to an intelligent, cloud-connected, and adaptively driven future possible for automobiles, electricity grids, satellites, and medical equipment.
  • Miruku — Miruku is a molecular farming dairy startup developing advanced dairy proteins through plant technologies that hold the potential to produce animal-free milk proteins cost-effectively.
  • Re-Leased Software Company Limited — Commercial property management software that makes life easier for property managers, landlords and owners.
Powerhouse Ventures VC Fund · Christchurch, Canterbury, New Zealand
powerHouse is a New Zealand intellectual property commercialisation company investing to develop new spin-out ventures
Show more
Investment focus
  • Solar, FinTech, Big Data
  • Seed, Series A, Funding Round
  • United States, France, New Zealand
Portfolio highlights
  • Granular — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
  • Granular Energy — Granular Energy provides solutions for managing and trading clean energy. We are the leading provider of energy certificate management software for utilities, helping to streamline certificate managment processes and enabling utilities to launch next-generation green offers, including transparency down to the hourly level.
  • Liquid Instruments — Redefining the way scientists, engineers, students, and professionals experience test and measurement with Moku software-reconfigurable hardware platforms
Tuhua Fund VC Fund · Auckland, Auckland, New Zealand
Micro-Venture Fund investing in 25 Kiwi Startups
Show more
Investment focus
  • Software, Internet, B2B
  • Seed, Series A, Angel
  • New Zealand, Singapore, United States
Portfolio highlights
  • Datch — Built on top of a powerful connected platform, the Datch Voice Assistant allows you to use the most natural form of communication - your voice - to converse with your site, allowing you to connect and interact with your existing in-house systems through simple integrations.
  • Dawn Aerospace — Delivering hardware to space. Positioning satellites on orbit. Returning products to Earth.
  • Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
Bridgewest Group VC Fund · San Diego, California, United States
Bridgewest Group is a closely held investment company with global assets in the biotech, wireless communications, infrastructure for "internet of things," semiconductor, real estate, and financial services industries.
Show more
Investment focus
  • Mobile, Hardware, Internet
  • Seed, Funding Round
  • New Zealand, United States
Portfolio highlights
  • Gimbal — The world's best brands and agencies rely on Infillion for advertising and software solutions that connect people, places, and digital experiences.
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
Quayside Holdings VC Fund
Quayside Holdings is the investment arm of the Bay of Plenty Regional Council which responsibly manages the listed assets, property, equities and private equity investments.
Show more
Investment focus
  • Sensor, FinTech, Hardware
  • Seed, Series B
  • New Zealand
Portfolio highlights
  • TradeWindow — TradeWindow provides the tools and support for exporters, importers, freight forwarders, and customs brokers to begin the journey to digital transformation.
  • WNT Ventures — New Zealand's Venture Capital Deep Tech Investor. Investing in Deeptech founders from Aotearoa to build local companies and help them go global
New Zealand Venture Investment Fund VC Fund · Auckland, Auckland, New Zealand
Your guide to finding and using government services.
Show more
Investment focus
  • Software, Biotechnology, SaaS
  • Seed, Series A, Angel
  • New Zealand, United States, Japan
Portfolio highlights
  • Insite AI — We create predictability for consumer brands in the unpredictable world of retail. Game-changing technology that attacks consumer brands' hardest problems.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
  • Surgical Design Studios — The Insides Company is the leading provider of chyme reinfusion solutions for intestinal failure
South Australian Venture Capital Fund VC Fund · Adelaide, South Australia, Australia
South Australian Venture Capital Fund - helping build dynamic and innovative South Australian startups / scaleups and accelerate their growth to a national and global scale.
Show more
Investment focus
  • Health Care, Biotechnology, Satellite Communication
  • Seed, Series B, Funding Round
  • Australia
Portfolio highlights
  • Fivecast — Fivecast is a global provider of open-source intelligence solutions, providing access and analysis of unprecedented amounts of digital data
  • Seonix Bio — Seonix Bio aims to improve the treatment and prevention of blinding eye disease by developing advanced risk prediction tools.
  • Pearler.AI — Pearler.AI is a software company that provides business development including advanced Ai, and software security.
Skip Capital VC Fund · Sydney, New South Wales, Australia · 5 investments in the past 12 months
Skip Capital is a private investment fund investing in technology and infrastructure
Show more
Investment focus
  • Software, Artificial Intelligence, SaaS
  • Series A, Seed, Series B
  • Australia, United States, Canada
Portfolio highlights
  • Atticus — Atticus makes fact-checking quick, collaborative and secure, so you can spend less time on process and more on the things that matter.
  • Lorikeet — Lorikeet provides AI customer support. Lorikeet offer its customers responsive, personalized, and effective support as table stakes.
  • Archistar.ai — Archistar's world-first artificial intelligence helps property professionals find profitable land development sites, assess for feasibility and generate dozens of architectural design strategies - all within a few minutes
National Vision VC Fund · Duluth, Georgia, United States
National Vision is the second largest and one of the fastest growing optical retail companies in the U.S., helping people to see their best to live their best. Learn more about National Vision Inc. and how to join our team.
Show more
Investment focus
  • Health Care, Social Media, Digital Media
  • Seed, Series A
  • New Zealand, United States
Portfolio highlights
  • Toku Eyes — Instant Healthcare Diagnostics. Toku Eyes developed a multi-modal artificial intelligence platform for instant healthcare diagnostics...
  • Digital Vision Systems — DigitalVision develops, manufactures, and distributes a technology platform for analyzing and correcting vision disorders. It offers vision simulators and prescribers, and spectacles and contact lenses. The company was founded in 2004 and is based in Atlanta, Georgia.
Booster VC Fund · Wellington, Wellington, New Zealand
Booster is an investment manager, superannuation and default KiwiSaver scheme provider. We offer ethical, New Zealand and specialist investment options.
Show more
Investment focus
  • Medical Device
  • Seed
  • New Zealand
Portfolio highlights
  • Avasa — Avasa is a medical device company. It helps to improve surgical procedures by developing novel implantable devices.
  • Bontia Bio — Bontia Bio is dedicated to creating natural parasiticides for crop protection and animal health.
  • PowerON — Dielectric Elastomers for Soft Robotics
CoAct Capital VC Fund · Melbourne, Victoria, Australia
Co:Act is an investment partnership of experienced venture investors with a network of founders.
Show more
Investment focus
  • Advice, Hospital, Software
  • Series A, Funding Round
  • Australia
Portfolio highlights
  • Knocknoc — Cybersecurity software company specialising in attack surface reduction technologies
  • Vantari VR — Virtual Reality for Healthcare
  • DASH Technology — DASH Technology provides financial services. They provide software, platform, and even wealth management space services. They provide advisers and broader wealth services. They provide inquiries through email, phone calls, and online applications.
Hostplus VC Fund · Melbourne, Victoria, Australia · 7 investments in the past 12 months
Join our leading Australian superannuation fund, committed to putting our members first, with a low admin fee and strong returns. Become a member today!
Show more
Investment focus
  • Software, Biotechnology, Renewable Energy
  • Series A, Series B, Series C
  • Australia, United Kingdom, United States
Portfolio highlights
  • Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providingreal-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.
  • Sonder — One app. One go-to. One support system.Sonder is the trusted wellbeing partner for some of the world’s most innovative organisations as they reimagine how to care and support their people.With a clear purpose of breaking down barriers to help, providing the right support to people at the right time. Acknowledging that there are often multiplefactors at play, and wellbeing comprises of cultural, social, environmental and vocational factors, all which play a part in getting to the root cause of issues, and on a path to wellness.The heart of Sonder's solution is a technology-driven platform supported in real time by medical and mental health experts - experts that are available every minute of every day. Their mission is to get the right outcome across any wellbeing or safety issue.Trusted by major corporations, education providers and Government to enhance wellbeing across the world, Sonder is on a mission to create a better world, accepting differences and supportive of others. A world where it's OK to ask for help, for anything, at any time of the day or night.It takes humans to help other humans. That’s why Sonder combines a human first, tech supported approach.
  • Cardiac Dimensions — Cardiac Dimensions, Inc. is a medical device company developing novel interventional tools for the treatment of heart failure and the related condition of mitral valve regurgitation. Our product, the Carillon® Mitral Contour System®, is a groundbreaking, non-surgical device developed to treat functional mitral valve regurgitation. Our system uses acatheter based approach to reshape the mitral valve and reduce mitral regurgitation.
Upswell Ventures VC Fund · Perth, Western Australia, Australia
We're an early-stage venture capital firm investing in technology companies at the Seed and Series A stage.
Show more
Investment focus
  • Software, Developer Tools, Apps
  • Seed, Series A, Funding Round
  • Australia, Canada, United Kingdom
Portfolio highlights
  • Amaka — Accounting integrations and automation solutions for SMBs. Sync data from POS and e-commerce business apps to Xero, QuickBooks, MYOB and more.
  • Riparide — Riparide helps you plan and book your next escape through our Storyteller travel guides. These guides, called Riparide Stories, come packed with unique stays, local adventures and social vibes....
  • Lasertrade — Lasertrade is an online marketplace that offers a wide range of medical devices and equipment for the healthcare sector.
LCO Capital VC Fund · Raleigh, North Carolina, United States
LCO Capital offer value-add financial and intellectual capital to underperforming business lines, using an LCO℠ business model.
Show more
Investment focus
  • Health Care, Manufacturing, Medical Device
  • Funding Round
  • New Zealand
Portfolio highlights
  • Chitogel — Chitogel is a medical device company that offers edge wound healing gel for use in endoscopic sinus surgery.
Andrew R Banks Angel · Sydney, New South Wales, Australia
Andrew R Banks
Show more
Investment focus
  • Grocery, Medical, Health Care
  • Seed
  • Australia
Portfolio highlights
  • Deliciou — Plant-based meat, seasonings, spices and condiments. Free worldwide shipping.
  • Osara Health — We empower people and organisations affected by cancer to thrive with our expertise, empathy and technology.
Auckland UniServices VC Fund · Perth, Western Australia, Australia
At UniServices, we partner with the University of Auckland to transform ideas into real-world solutions that impact globally.
Show more
Investment focus
  • Medical, Marketing, Health Care
  • Seed, Pre-Seed
  • New Zealand
Portfolio highlights
  • eVouch — eVouch is the most powerful marketing tool we've used to build an organic community. We've experienced elevated brand trust while reaching an audience we never thought possible. Using customers to market to their friends is simply genius.
  • Kitea Health — Kitea Health creates pressure monitoring implantable medical devices.
Significant Early Venture Capital VC Fund · Canberra, Australian Capital Territory, Australia
With over two decades of Australian investment in building capability in research and universities, Australia now enjoys some of the most extraordinary talent and globally leading minds.This talent is creating knowledge and has the capacity of solving some of the big problems of our time but if we can’t take this know-how and intellect into theworld, then this brilliance is lost and the opportunity we have will remain just that – an opportunity.As business builders and investors, Significant has been taking up this challenge for nearly two decades. Working in collaboration with universities, researchers and state governments, we, as a collective group have a track record in translating this knowledge bank into technology, into products, into services and ultimately into businesses that:- Have become global companies- Re-shaped markets- Solved sustainability problems- Created jobs and- New career pathways for AustraliansSignificant has the capacity to create high value niche modern manufacturing industries and exports for Australia and are extremely proud of their achievements.Significant leads by example to show that Australia can commercialise its inventions, that sustainable globally competitive businesses can be created in Australia, and that early-stage investment can create immense value for investors, demonstrating that through action Significant is able to attract more capital to invest in this important space and is be able to shift the mindset (read the AFR article) that Australia is great at innovation but not at execution.
Show more
Investment focus
  • Software, Information Technology, Electronics
  • Seed, Series A, Pre-Seed
  • Australia
Portfolio highlights
  • Cyban — Advancing the way brain injuries are detected and managed
  • Earthodic — Earthodic is an Australian materials science company creating functional biobased coatings. Paperbarc by Earthodic is a biobased water-resistant coating for pulped or paper products. It has better water-resistance than wax coatings, more sustainable and circular than plastic coatings. Repulpable. Re
  • Vantari VR — Virtual Reality for Healthcare
Investors by industry
Investors by country
Investors in Oceania by industry